Adult mesenchymal stem cells: Potential for muscle and tendon regeneration and use in gene therapy

Journal of Musculoskeletal Neuronal Interactions

Volumn 2, Issue 4, 2002, Pages 309-320

  Pittenger, Mark ^a   Vanguri, P ^a   Simonetti, D ^a   Young, R ^a  

^a OSIRIS THERAPEUTICS INC   (United States)

Author keywords

Adult stem cells; Cardiac; Differentiation; Gene therapy; Mesenchymal stem cells; Myogenic; Stem cells; Tendon; Tissue regeneration

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BLOOD CLOTTING FACTOR 9; ERYTHROPOIETIN; GENE PRODUCT; GLUCOSYLCERAMIDASE; GROWTH HORMONE; NEUROTROPHIC FACTOR; OSTEOGENIC PROTEIN 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; CARDIOMYOPLASTY; CELL DIFFERENTIATION; CONNECTIVE TISSUE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; KNEE MENISCUS; LIGAMENT; MESENCHYME CELL; MOUSE; MUSCLE ATROPHY; MUSCLE REGENERATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHENOTYPE; RAT; REVIEW; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION; TENDON RECONSTRUCTION; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM;

EID: 0036621015     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Martin GR. Isolation of pluripotent cell lines from early mouse embryos in medium conditioned by teratocarcinome stem cells. Proc Natl Acad Sci USA 1981; 78:7634-7638.
2. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embyros. Nature 1981; 292:154-156.
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
4. Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95:13726-13731.
5. Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2000; 97:11307-11312.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
7. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284:1168-1170.
8. Bjornson CRR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999; 283:534-537.
9. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev Biol 1996; 32:602-611.
10. Pittenger MP, Mbalaviele G, Black M, Mosca JD, Marshak DR. Mesenchymal stem cells. In: Koller MR, Palsson BO and Masters JRW (eds) Human cell culture Vol 5 primary mesenchymal cells. Kluwer Academic Publishers, Dordrecht; 2001.
11. Jacobson LO, Marks EK, Robson MF, Gaston EO, Zirkle RE. Effect of spleen protection on mortality following X irradiation. J Lab Clin Med 1949; 34:1538-1547.
12. Lorenz E, Uphoff D, Reid TR, Shelton T. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst 1951; 12:197-201
13. McCulloch EA, Till JE. Proliferation of hematopoietic colony-forming cells transplanted into irradiated mice. Rad Res 1964; 22:383-387.
14. Thomas ED, Blume KG. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 1999; 5:341-346.
15. Huggins CB. The formation of bone under the influence of the epithelium of the urinary tract. Archives of Surgery 1931; 22:377-408.
16. Urist MR, McLean FC. Osteogenic potence and new bone formation by induction in transplants to the anterior chamber of the eye. J Bone Joint Surg (Am) 1961; 34:443-470.
17. Tavassoli M, Crosby WH. Transplantation of marrow to extramedullary sites. Science 1968; 161:548-556.
18. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16:381-390.
19. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic transplants of bone marrow: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968; 6:230-247.
20. Kuznetsov SA, Friedenstein AJ, Robey PG. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol 1997; 97:561-570.
21. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, Mckenzie S, Broxmeyer HE, Moore MAS. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56:289-301.
22. Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthop 1980; 151:294-307.
23. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 1992; 102:341-351.
24. Owen ME. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck WA (ed) Bone and mineral research Vol 3. Elsevier, New York; 1985:1-25.
25. Owen ME, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Foundation Symposium 1988; 136:42-60.
26. Caplan AI. Mesenchymal Stem Cells. J Orthop Res 1991; 9:641-650.
27. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human bone marrow. Bone 1992; 13:81-88.
28. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethsone and IL-1a. J Cell Physiol 1996; 166:585-592.
29. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995; 18:1417-1426.
30. Saito T, Dennis JE, Lennon DP, Young RG, Caplan AI. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tissue Eng 1995; 4:327-342.
31. Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279:1528-1530.
32. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, Grupp SA, Sieff CA, Mulligan RC, Johnson RP. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 12:1337-1345.
33. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci 1999; 96:14482-14486.
34. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401:390-394.
35. Bittner RE, Schofer C, Weipoltshammer K, Ivanova S, Streubel B, Hauser E, Freilinger M, Hoger H, Elbe-Burger A, Wachtler F. Recruitment of bone marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) 1999; 199:391-396.
36. Wang JS, Shum-Tim D, Galipeau J, Chewdrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000; 120:999-1005.
37. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SA, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701-705.
38. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105:93-98.
39. Floyd SS Jr, Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, Balkir L, Morgan J, Moreland MS, Feero GW, Epperly M, Huard J. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 1998; 1:19-30.
40. Lee JY, Qu-Peterson Z, Cao B, Kimura S, Jankowski R, Cummins J, Usas A, Gates C, Robbins P, Wernig A, Huard J. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000; 150:1085-1100.
41. Day CS, Bosch P, Kasemkijwattana C, Menetrey J, Moreland MS, Fu FH, Ziran B, Huard J. Use of muscle cells to mediate gene transfer to the bone defect. Tissue Eng 1999; 2:119-125.
42. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 1991; 254:1509-1512.
43. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998; 2:549-558.
44. Dai Y, Roman M, Naviaux RK, Verma IM. Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 1992; 89:10892-10895.
45. Wang J-M, Zheng H, Blaivas M, Kurachi K. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels. Blood 1997; 90:1075-1082.
46. Hamamori Y, Small B, Tian J, Kedes L. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest 1995; 95:1808.
47. Liu C, Dunigan JT, Watkins SC, Bahnson AB, Barranger JA. Long-term expression, systemic delivery, and macrophage uptake of recombinant human glucocerebrosidase in mice transplanted with genetically modified primary myoblasts. Hum Gene Ther 1998; 9:2375-2384.
48. Hortelano G, Xu N, Vandenberg A, Solera J, Chang PL, Ofosu FA. Persistent delivery of factor IX in mice: Gene therapy for hemophilia using implantable microcapsules. Hum Gene Ther 1999; 10:1281-1288.
49. Mohajeri MH, Figlewicz DA, Bohn MC. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 1999; 10:1853-1866.
50. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang LC, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop 2000; 379:S71-90.
51. Lee K, Majumdar MK, Buyaner D, Hendricks JK, Pittenger MF, Mosca JD. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 2001; 3:857-866.
52. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal cells: nature, biology, and potential applications. Stem Cells 2001; 19:180-192.
53. Leichty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R, Marshak DR, Flake AW. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6:1282-1286.
54. Devine SM, Bartholomew, AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C, Hewett T, Chung T, Stock W, Sher D, Weissman S, Ferrer K, Mosca J, Deans R, Moseley A, Hoffman R. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 2:244-55.
55. Skuk D, Roy B, Goulet M, Tremblay JP. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 1999; 155:22-30.
56. Liu LN, Hendricks K, Buyaner D, Lee K, Boehnlein E, Junker U, Deans RJ, Vanguri P, Mosca JD. Systemic erythropoietin expression from human mesenchymal stem cells depends on both cell adherence and delivery route. The International Society for Hematotherapy and Graft Engineering Meeting, San Diego, CA, 2000.
57. Liu, LN, Wang G, Hendricks K, Buyaner D, Lee K, Bohnlein E, Junker U, Mosca JD. Expression of soluble TNF-RII from transduced human mesenchymal stem cells prevents arthritis in a Balb/SCID mouse model. Mol Ther 2000; 1:S197.
58. Lund AH, Duch M, Pederson FS. Transcriptional silencing of retroviral vectors. J Biomed Sci 1996; 3:365-378.
59. Hawley RG. Progress toward vector design for hematopoietic stem cell gene therapy. Current Gene Ther 2001; 1:1-17.
60. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8:803-815.
61. Best TM, Garrett WE. Basic science of soft tissue muscle and tendon. In: DeLee JC (ed) Orthopaedic sports medicine. WB Saunders, Philadelphia, USA; 1994:25-45.
62. Woo SL, Hildebrand K, Watanabe N, Fenwick JA, Papageorgiou CD, Wang JH. Tissue engineering of ligament and tendon healing. Clin Orthop 1999; 367(Suppl):S312-323.
63. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 1994; 4:579-592.
64. Young RG, Butter DL, Weber W, Caplan AI, Gordon SL, Fink DJ. The use of mesenchymal stem cells in Achilles tendon repair. J Orthop Res 1998; 16:406-413.
65. Awad HA, Butler DL, Harris MT, Ibrahim RE, Wu Y, Young RG, Kadiyala S, Boivin GP. In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: Effects of initial seeding density on contraction kinetics. J Biomed Mater Res 2000; 51:233-240.
66. Archambault MP, Peter SJ, Young RY. Effects of cyclic tension on matrix synthesis and tissue formation in a three-dimensional culture system. Transactions of the 46th Annual Meeting, Orthopaedic Research Society, 2000; Poster No. 0636.
67. Nurminskaya MV, Birk DE. Differential expression of genes associated with collagen fibril growth in the chicken tendon: identification of structural and regulatory genes by subtractive hybridization. Arch Biochem Biophys, 1998; 350:1-9.
68. Ros MA, Rivero FB, Hinchliffe JR, Hurle JM. Immunohistological and ultrastructural study of the developing tendons of the avian foot. Anat Embryol (Berl) 1995; 192:483-96.
69. Awad HA, Butler DL, Boivin GP, Dressler MR, Smith FNL, Young RG. Effects of implant seeding density on MSC-mediated repair of patellar tendon injuries. Transactions of the 46th Annual Meeting, Orthopaedic Research Society, 2000; No. 048.
70. Cook JL, Tomlinson JL, Kreeger JM, Cook CR. Induction of meniscal regeneration in dogs using a novel biomaterial. Am J Sports Med 1999; 27:658-665.
71. Peretti GM, Caruso EM, Randolph MA, Zaleske DJ. Meniscal repair using engineered tissue. J Orthop Res 2001;19:278-285.
72. Arnoczky SP. Building a meniscus: Biologic considerations. Clin Orthop 1999; 367 (Suppl):S244-253.
73. Bullough PG, Munuera L, Murphy J, Weinstein AM. The strength of the menisci of the knee as it relates to their fine structure. J Bone Joint Surg Br 1970; 52:564-567.
74. Murphy M, Kavalkovich K, Barry F. Distribution of injected mesenchymal stem cells in the osteoarthritic knee. Transactions of the 47th Annual Meeting of the Orthopaedic Research Society 2001, Poster No. 0656.
75. Murphy M, Kavalkovich K, Fink F, Hunziker E, Barry F. Injected mesenchymal stem cells stimulate meniscal repair and protection of articular cartilage. Transactions of the 47th Annual Meeting of the Orthopaedic Research Society 2001, Poster No. 0193.
76. Walsh CJ, Goodman D, Caplan AI, Goldberg VM. Meniscus regeneration in a rabbit partial meniscectomy model. Tissue Eng 1999; 5:327-337.
77. Angele P, Johnstone B, Kujat R, Nerlich M, Goldberg V, Yoo J. Meniscus repair with mesenchymal progenitor cells in a biodegradable composite matrix. Transaction of the 46th Annual Meeting, Orthopaedic Research Society 2000; Poster No. 0605.
78. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16:557-564.
79. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM. Rapid hematopoietic recovery after coinfusion of autologous blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol 2000; 18:307-316.
80. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WWK, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5:309-313.